Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO Establishes Principles For Follow-on Biologics To Guide Lawmakers

This article was originally published in The Pink Sheet Daily

Executive Summary

In letters sent to legislators, BIO asks Congress to adopt the principles, emphasizing patient health and biotech innovation.

You may also be interested in...



PDUFA Bill Moves To Senate Mark-Up, But Without Generic Biologics Language

April 18 session is planned in the HELP Committee as advocates for follow-on pathway continue to press their case.

PDUFA Bill Moves To Senate Mark-Up, But Without Generic Biologics Language

April 18 session is planned in the HELP Committee as advocates for follow-on pathway continue to press their case.

Exclusivity For Biologics Should Potentially Be Longer Than For Small Molecule Drugs – BIO Exec

In debate over follow-on biologics pathway, BIO and GPhA agree on little except the need to lay out intellectual property ground rules.

Related Content

Topics

UsernamePublicRestriction

Register

PS065828

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel